Structure Therapeutics Announces Pricing of Upsized $476 Mil

SAN FRANCISCO, June 05, 2024 -- Structure Therapeutics Inc. , a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary...

Related Keywords

Boston , Massachusetts , United States , New York , American , Dan Budwick , Danielle Keatley , Equity Syndicate Prospectus Department , Morgan Stanley Co , Syndicate Department , Equity Syndicate Department , Structure Therapeutics Inc , Guggenheim Securities , Exchange Commission , Capital Markets Corp , Morgan Stanley , Prospectus Department , Nasdaq , Goldman Sachs Co , Structure Therapeutics , Leerink Partners , Markets Corp , Private Securities Litigation Reform Act , Annual Report , Quarterly Report ,